Trulieve Cannabis Corp.
TRLV | NYSE
$10.28
-$0.32 (-3.02%)
At close: Oct 30, 2026, 4:00 PM ET
$10.40
+$0.12 (+1.17%)
Pre-market:
Nov 2, 2026, 4:58 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -122.25M |
Depreciation & Amortization | 173.4M |
Stock-Based Compensation | 20.47M |
Other Working Capital | 214.08M |
Other Non-Cash Items | 31.59M |
Deferred Income Tax | -18.55M |
Change in Working Capital | 188.17M |
Operating Cash Flow | 272.82M |
Capital Expenditures | -60.51M |
Cash Acquisitions | n/a |
Purchase of Investments | n/a |
Sales Maturities Of Investments | 60M |
Other Investing Acitivies | -2.31M |
Investing Cash Flow | 13.5M |
Debt Repayment | -393.35M |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | -17.15M |
Financial Cash Flow | -270.5M |
Net Cash Flow | 15.83M |
Free Cash Flow | 212.31M |
Adj. Free Cash Flow | 191.85M |
Maintenance CapEx | -60.51M |
Growth CapEx | n/a |
Owner Earnings | 212.31M |
Add to Watchlist
Select watchlists to add or remove TRLV